Snap Gets a Slew of Analyst Downgrades After Latest Earnings Report | Price Target Changes

Benzinga2022-07-22
  • Barclays cut AT&T Inc. price target from $22 to $20. AT&T shares fell 0.6% to $18.81 in pre-market trading.
  • UBS cut the price target on The Scotts Miracle-Gro Company from $125 to $92. Scotts Miracle-Gro shares fell 0.9% to $86.45 in pre-market trading.
  • Keybanc reduced Atlassian Corporation Plc price target from $338 to $278. Atlassian shares fell 0.2% to $213.73 in pre-market trading.
  • SVB Leerink raised 1Life Healthcare, Inc. price target from $9 to $18. 1Life Healthcare shares fell 0.4% to $17.18 in pre-market trading.
  • Raymond James reduced D.R. Horton, Inc. price target from $120 to $103. D.R. Horton shares fell 0.2% to $75.70 in pre-market trading.

Several analysts made changes to their price targets on Snap following the release of results.

  • Citigroup lowered price target on the stock from $29 to $16.
  • RBC Capital lowered Snap price target from $17 to $10.
  • Barclays cut the price target on the stock from $20 to $15.
  • Rosenblatt lowered the price target from $23 to $14.
  • JMP Securities lowered Snap price target from $42 to $24.
  • Benchmark cut the price target on the stock from $20 to $15.
  • Credit Suisse lowered Snap price target from $45 to $35.
  • Evercore ISI Group cut the price target on the stock from $26 to $14.
  • Piper Sandler lowered Snap price target from $18 to $11.
  • Stifel cut the price target on the stock from $20 to $14.
  • Goldman Sachs lowered Snap price target from $25 to $12.
  • Atlantic Equities cut the price target on the stock from $18 to $13.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
7